| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q4V7X3 | XNop56 protein; Fragment; | XNop56; | NULL | 510 | clawed frog |
| Q4V7G5 | MGC115732 protein; | arl14ep; MGC115732; | NP_001090061.1; | 140 | clawed frog |
| Q4QQX8 | Uncharacterized protein; Fragment; | NULL | NULL | 79 | clawed frog |
| Q4KLR4 | MGC115596 protein; | phldb1; MGC115596; | NP_001089596.1; | 743 | clawed frog |
| Q566G1 | MGC115350 protein; | MGC115350; | NP_001089376.1; | 493 | clawed frog |
| Q3KQA7 | Ccnb3-a protein; | ccnb3-a; | NULL | 415 | clawed frog |
| Q52KX3 | MGC115258 protein; | pcsk7; MGC115258; | NP_001090019.1; | 754 | clawed frog |
| Q58E78 | MGC85066 protein; | MGC85066; | NP_001090276.1; | 279 | clawed frog |
| Q56VD1 | BH3 interacting domain death agonist; | bid; | NP_001089063.1; | 184 | clawed frog |
| Q5EAW3 | MGC84921 protein; | mgc75753; MGC84921; | NP_001089992.1; | 153 | clawed frog |
| Q58E88 | MGC84927 protein; | slc2a13; MGC84927; | NP_001089323.1; | 604 | clawed frog |
| Q599J7 | Beta-3-glucuronyltransferase-S; EC 2.4.1.135; | b3gat2; | NP_001089073.1; | 330 | clawed frog |
| Q5FWK9 | MGC85120 protein; | MGC85120; | NP_001089264.1; | 483 | clawed frog |
| Q566I4 | LOC446268 protein; | LOC446268; | NULL | 579 | clawed frog |
| Q5U548 | LOC495372 protein; | mmp8; LOC495372; | NP_001088503.1; | 466 | clawed frog |
| Q4V825 | LOC443659 protein; Fragment; | LOC443659; | NULL | 218 | clawed frog |
| Q5U544 | St3Gal-VI protein; | st3Gal-VI; | NULL | 324 | clawed frog |
| Q5V9L8 | Cyclin dependent kinase inhibitor p16Xic3; | cdkn1b; | NP_001087934.1; | 141 | clawed frog |
| Q641F7 | MGC81732 protein; | ppid; MGC81732; | NP_001087854.1; | 370 | clawed frog |
| Q66IS3 | MGC85260 protein; | pstpip1; MGC85260; | NP_001087785.1; | 409 | clawed frog |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |